Clinical Trial Update: Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for HRS-4357 in patients with advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HRS-4357

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN